Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Nov;50(11):3651-7.
doi: 10.1128/AAC.00622-06.

Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide

Affiliations

Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide

Randal Eckert et al. Antimicrob Agents Chemother. 2006 Nov.

Abstract

Within the repertoire of antibiotics available to a prescribing clinician, the majority affect a broad range of microorganisms, including the normal flora. The ecological disruption resulting from antibiotic treatment frequently results in secondary infections or other negative clinical consequences. To address this problem, our laboratory has recently developed a new class of pathogen-selective molecules, called specifically (or selectively) targeted antimicrobial peptides (STAMPs), based on the fusion of a species-specific targeting peptide domain with a wide-spectrum antimicrobial peptide domain. In the current study, we focused on achieving targeted killing of Streptococcus mutans, a cavity-causing bacterium that resides in a multispecies microbial community (dental plaque). In particular, we explored the possibility of utilizing a pheromone produced by S. mutans, namely, the competence stimulating peptide (CSP), as a STAMP targeting domain to mediate S. mutans-specific delivery of an antimicrobial peptide domain. We discovered that STAMPs constructed with peptides derived from CSP were potent against S. mutans grown in liquid or biofilm states but did not affect other oral streptococci tested. Further studies showed that an 8-amino-acid region within the CSP sequence is sufficient for targeted delivery of the antimicrobial peptide domain to S. mutans. The STAMPs presented here are capable of eliminating S. mutans from multispecies biofilms without affecting closely related noncariogenic oral streptococci, indicating the potential of these molecules to be developed into "probiotic" antibiotics which could selectively eliminate pathogens while preserving the protective benefits of a healthy normal flora.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Selective killing activity of C16G2 against S. mutans. S. mutans, S. sanguinis, and S. gordonii planktonic cells were exposed to 25 μM of the STAMP C16G2, or its untargeted parent antimicrobial peptide G2, for 1 min. Surviving CFU per milliliter were detected and compared. Data represent averages of the results of at least three independent experiments.
FIG. 2.
FIG. 2.
Inhibitory activity of G2 and C16G2 against single-species biofilms. S. gordonii (A), S. sanguinis (B), and S. mutans (C) monoculture biofilms were grown and then exposed for 1 min to a 25 μM concentration of STAMP or a STAMP component (as indicated in the figure), washed, and regrown with fresh medium. Biofilm recovery was monitored over time by OD600. Data represent averages of the results from three independent experiments.
FIG. 3.
FIG. 3.
C16G2 activity against S. mutans within a multispecies biofilm. Mixed cultures of S. mutans, S. sanguinis, and S. gordonii were allowed to form a biofilm in saliva and were then exposed to 25 μM C16G2, CSPC16, or G2. After being washed, the biofilms were allowed to recover in fresh medium-saliva. The regrowth of the biofilm over time was monitored by measuring absorbance at OD600, while the health of the S. mutans within the biofilm was measured by luciferase activity (RLU production). The data were plotted as RLU/OD600 and represent averages of the results of at least three independent experiments.
FIG. 4.
FIG. 4.
Activity of M8G2 against oral bacteria in biofilms. S. mutans (A) or S. sanguinis (B) single-species biofilms were mock treated or exposed to 25 μM M8G2 (as specified in the figure). After removal of the STAMP and the addition of fresh medium, biofilm recovery was monitored over time by monitoring absorbance at OD600. The data represent the averages of the results of three independent experiments.
FIG. 5.
FIG. 5.
Biofilm-inhibitory activity of S6L3-33 and S6L3-33-containing STAMPs. Single-species biofilms of S. mutans (A) or S. sanguinis (B) were treated with M8-33, C16-33, or S6L3-33 alone (as specified in the figure) for 1 min. After agent removal and stringent washing, the regrowth of the biofilms was tracked over 4 h by measuring absorbance at OD600 after the addition of fresh medium. The data represent average values obtained from the results of at least three independent assays.

References

    1. Aas, J. A., B. J. Paster, L. N. Stokes, I. Olsen, and F. E. Dewhirst. 2005. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43:5721-5732. - PMC - PubMed
    1. Ajdic, D., W. M. McShan, R. E. McLaughlin, G. Savic, J. Chang, M. B. Carson, C. Primeaux, R. Tian, S. Kenton, H. Jia, S. Lin, Y. Qian, S. Li, H. Zhu, F. Najar, H. Lai, J. White, B. A. Roe, and J. J. Ferretti. 2002. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc. Natl. Acad. Sci. USA 99:14434-14439. - PMC - PubMed
    1. Anderson, M. H., and W. Shi. 2006. A probiotic approach to caries management. Pediatr. Dent. 28:151-153. - PubMed
    1. Anonymous. 2002. Infectious diseases—dental caries. Washington State Department of Health, Olympia, Wash.
    1. Anonymous. 2000. Oral health in America: a report of the Surgeon General. Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Md.

Publication types